Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
Mutagenesis
|
November 4, 1998
Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells
L S Clark, D W Hart, P J Vojta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1990
Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma
H Gurney, D Crowther, H Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles
D Murphy, D Crowther, J Renninson, et al.
Plos One
|
May 16, 2024
Relationships between genomic dissipation and de novo SNP evolution
Zackery E Plyler, Christopher W McAtee, Aubrey E Hill, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2002
Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis
Shiquan Liu, Wenjing Liu, John L Jakubczak, et al.
British Medical Journal
|
October 31, 1970
A male sterilization clinic
P Jackson, B Phillips, E Prosser, et al.
Cancer Research
|
October 27, 1997
Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6
A Umar, M Koi, J I Risinger, et al.
Cancer Letters
|
September 30, 1999
Mutagenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the new gpt delta transgenic mouse
K Masumura, K Matsui, M Yamada, et al.
Environmental and Molecular Mutagenesis
|
January 1, 1994
Sources of variability in data from a lacI transgenic mouse mutation assay
W W Piegorsch, A M Lockhart, B H Margolin, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
November 17, 2025
Fibroblast-specific targeting of bone morphogenetic protein signaling molecules does not alter the outcome of alcohol-associated chronic pancreatitis in mice
Kevin H Shi, Isabella E Hernandez, Amanda C Bean, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
Mutagenesis
|
November 4, 1998
Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells
L S Clark, D W Hart, P J Vojta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1990
Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma
H Gurney, D Crowther, H Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles
D Murphy, D Crowther, J Renninson, et al.
Plos One
|
May 16, 2024
Relationships between genomic dissipation and de novo SNP evolution
Zackery E Plyler, Christopher W McAtee, Aubrey E Hill, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2002
Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis
Shiquan Liu, Wenjing Liu, John L Jakubczak, et al.
British Medical Journal
|
October 31, 1970
A male sterilization clinic
P Jackson, B Phillips, E Prosser, et al.
Cancer Research
|
October 27, 1997
Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6
A Umar, M Koi, J I Risinger, et al.
Cancer Letters
|
September 30, 1999
Mutagenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the new gpt delta transgenic mouse
K Masumura, K Matsui, M Yamada, et al.
Environmental and Molecular Mutagenesis
|
January 1, 1994
Sources of variability in data from a lacI transgenic mouse mutation assay
W W Piegorsch, A M Lockhart, B H Margolin, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
November 17, 2025
Fibroblast-specific targeting of bone morphogenetic protein signaling molecules does not alter the outcome of alcohol-associated chronic pancreatitis in mice
Kevin H Shi, Isabella E Hernandez, Amanda C Bean, et al.
Page
of 12